William Blair & Company’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-5,339
Closed -$409K 1921
2021
Q4
$409K Sell
5,339
-431
-7% -$38K ﹤0.01% 1296
2021
Q3
$555K Sell
5,770
-98
-2% -$10.7K ﹤0.01% 1119
2021
Q2
$626K Sell
5,868
-36
-0.6% -$3.54K ﹤0.01% 1077
2021
Q1
$529K Buy
5,904
+159
+3% +$17.5K ﹤0.01% 1104
2020
Q4
$577K Buy
5,745
+730
+15% +$54.4K ﹤0.01% 1043
2020
Q3
$245K Sell
5,015
-406
-7% -$19.5K ﹤0.01% 1210
2020
Q2
$221K Buy
+5,421
New +$156K ﹤0.01% 1203

Other funds holding CRNC

William Blair & Company's CRNC Position: Q1 2022 in Review

William Blair & Company sold out of Cerence (CRNC) in Q1 2022, closing a stake of 5,339 shares — an estimated $409K sold.

William Blair & Company first reported a position in CRNC in Q2 2020 and held it in 7 quarters. The position peaked at $626K in Q2 2021. 286 funds tracked by Wall St. Rank hold CRNC as of Q1 2022.

  • William Blair & Company reported no remaining Cerence position as of Q1 2022 after selling out during the quarter.
  • William Blair & Company sold 5,339 Cerence shares in Q1 2022, an estimated $409K.
  • William Blair & Company first reported a position in Cerence in Q2 2020 and held it in 7 quarters.
  • William Blair & Company's Cerence position peaked at $626K in Q2 2021.
  • 286 funds tracked by Wall St. Rank held Cerence as of Q1 2022.

Based on William Blair & Company's 13F filing for Q1 2022, filed 13 May 2022.